Dyne Therapeutics (NASDAQ: DYN)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Dyne Therapeutics (NASDAQ: DYN) through any online brokerage.
There are no as such competitors for Dyne Therapeutics.
The latest price target for Dyne Therapeutics (NASDAQ: DYN) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting DYN to fall to within 12 months (a possible -66.80% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Dyne Therapeutics (NASDAQ: DYN) is $12.05 last updated August 12, 2022, 8:00 PM UTC.
The next Dyne Therapeutics (DYN) dividend date is projected to be Thursday, September 1, 2022.
Dyne Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Dyne Therapeutics.
Dyne Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.